Pre-existing singleton E138A mutations in the reverse transcriptase gene do not affect the efficacy of first-line antiretroviral therapy regimens using rilpivirine in human immunodeficiency virus-infected patients

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Kuznetsova A, Lebedev A, Gromov K, Kazennova E, Zazzi M, Incardona F, Sönnerborg A, Bobkova M

Journal title: Clinical Case Reports

Journal number: 10/2

Journal publisher: John Wiley & Sons Ltd

Published year: 2022

DOI identifier: 10.1002/ccr3.5373

ISSN: 2050-0904